• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec9
Viking Therapeutics Inc. Updates Clinical Pipeline, Emphasizes Progress in Metabolic and Endocrine Disease Programs
00:41
Dec3
Scotia Capital Acquires Shares of Viking Therapeutics
11:43
Nov25
Rockefeller Capital Management Increases Holdings in Viking Therapeutics, Inc.
10:47
Nov21
Zacks Research Raises Viking Therapeutics' Rating to Hold
11:26
Viking Therapeutics Completes Enrollment in VK2735 Phase III Clinical Trial
10:00
Nov19
William Blair and Canaccord Genuity Maintain Buy Rating on Viking Therapeutics Stock
15:28

Schedules & Filings

Schedules
Filings
Oct22
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -90.79 M, EPS -0.8082

Jul23
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -65.56 M, EPS -0.5846

Apr23
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -45.63 M, EPS -0.4071

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More